Featured in Generalized Pustular Psoriasis (GPP)
Weekly Featured
Exploring a New Approach to Generalized Pustular Psoriasis
Discover this week's featured video and expert opinion
Latest Generalized Pustular Psoriasis (GPP) Videos
Generalized Pustular Psoriasis (GPP)
GPP vs Plaque Psoriasis: Recognizing the Differences That Matter
Featuring Jason Hawkes, MD, MS | Tina Bhutani-Jacques, MD, MAS
Generalized Pustular Psoriasis (GPP)
GPP in Every Patient: Understanding Its Diverse Presentations for Better Treatment Outcomes
Featuring Ronald Vender, MD | Raj Chovatiya, MD, PhD, MSCI
Featured CME on Generalized Pustular Psoriasis (GPP)
0.5 Credit
Click to save this course
Generalized Pustular Psoriasis (GPP)
CME
Shifting the Management Paradigm in Generalized Pustular Psoriasis
Release Date
December 12, 2025
0.5 Credit
Click to save this course
Generalized Pustular Psoriasis (GPP)
CME
FC24: Managing Generalized Pustular Psoriasis From Flare to Maintenance: Optimizing Patient Outcomes: An Online Activity
Release Date
January 10, 2025
Generalized Pustular Psoriasis (GPP) Case Study
Generalized Pustular Psoriasis (GPP)
Intravenous and subcutaneous spesolimab use in a medically comorbid patient with erythrodermic generalized pustular psoriasis
Case author Angad Arinder Chadha, MD, presents a case of a 72-year-old African American female admitted for management of a generalized pustular psoriasis...
Show moreGeneralized Pustular Psoriasis (GPP) News & Research
Flares Occur Frequently in Generalized Pustular Psoriasis
Frequent treatment alterations of off-label biologics and nonsteroidal systemic agents observed
By Elana Gotkine (HealthDay News) | | April 16, 2025
International Consensus Achieved for Generalized Pustular Psoriasis
Final definition is 'systemic inflammatory disease characterized by cutaneous erythema and macroscopically visible sterile pustules'
By Dermsquared Editorial Team | | May 01, 2024
LAUNCH ALERT: SPEVIGO expanded indications now available in the US
The US FDA’s expanded approval makes SPEVIGO the first targeted therapy that addresses the need for acute and chronic treatment for patients with GPP.
By Dermsquared Editorial Team | | May 02, 2024